p21 expression is a prognostic factor in patients with p53-negative gastric cancer

Harper, 1993, The p21 cdk-interacting protein Cip1 is a potent inhibitor of C1 cyclin-dependent kinases, Cell, 75, 805, 10.1016/0092-8674(93)90499-G Xiong, 1993, p21 is a universal inhibitor of cyclin kinases, Nature, 366, 701, 10.1038/366701a0 O'Connor, 1997, Mammalian G1 and G2 phase checkpoints, Cancer Surv., 29, 151 Luo, 1995, Cell cycle inhibition by independent Cdk and PCNA binding domains in p21Cip1, Nature, 375, 159, 10.1038/375159a0 Chen, 1995, Direct interaction of Gadd45 with PCNA and evidence for competitive interaction of Gadd45 and p21 Waf1/Cip1 with PCNA, Oncogene, 11, 1931 Kawasaki, 1996, Abrogation of apoptosis induced by DNA-damaging agents in human bladder-cancer cell lines with p21(waf1/cip1) and/or p53 gene alterations, Int. J. Cancer, 68, 501, 10.1002/(SICI)1097-0215(19961115)68:4<501::AID-IJC16>3.0.CO;2-7 Oh, 1998, Induction of p21 during ceramide-mediated apoptosis in human hepatocarcinoma cells, Cancer Lett., 129, 215, 10.1016/S0304-3835(98)00105-0 Michieli, 1994, Induction of WAF1/CIP1 by a p53-independent pathway, Cancer Res, 54, 3391 Akagi, 1996, Inhibition of cell growth by transforming growth factor β1 is associated with p53-independent induction of p21 in gastric carcinoma cells, Jpn. J. Cancer Res., 87, 377, 10.1111/j.1349-7006.1996.tb00233.x Parker, 1995, p53-independent expression of p21WAF1/Cip1 in muscle and other terminally differentiating cells, Science, 267, 1024, 10.1126/science.7863329 Macleod, 1995, p53-dependent and independent expression of p21 during cell growth differentiation, and DNA damage, Genes Dev., 9, 935, 10.1101/gad.9.8.935 Okayasu, 1998, p53 and p21 (WAF1) expression in lymphocytic thyroiditis and thyroid tumors, Clin. Immunol. Immunopathol., 88, 183, 10.1006/clin.1998.4572 Sinicrope, 1998, Loss of p21WAF1/CIP1 protein expression accompanies progression of sporadic colorectal neoplasms but not hereditary nonpolyposis colorectal cancers, Clin. Cancer Res, 4, 1251 Lipponen, 1998, Expression of 21(waf1/cip1) protein in transitional cell bladder tumors and its prognostic value, Eur. Urol., 34, 237, 10.1159/000019721 Lu, 1998, Expression of p21WAF1/CIP1 in adenocarcinoma of the uterine cervix, Cancer, 82, 2409, 10.1002/(SICI)1097-0142(19980615)82:12<2409::AID-CNCR15>3.0.CO;2-T Hu, 1998, Infrequent expression of p21 is related to altered p53 protein in pancreatic carcinoma, Clin. Cancer Res., 4, 1147 Elbendary, 1996, Relationship between p21 expression and mutation of the p53 tumor suppressor gene in normal and malignant ovarian epithelial cells, Clin. Cancer Res., 2, 1571 Caffo, 1996, Prognostic value of p21WAF1 and p53 expression in breast carcinoma: an immunohistochemical study in 26 patients with long-term follow-up, Clin. Cancer Res., 2, 1591 Yasui, 1996, Expression of cyclin-dependent kinase inhibitor p21WAF1/CIP1 in non-neoplastic mucosa and neoplasia of the stomach: relationship with p53 status and proliferative activity, J. Pathol., 180, 122, 10.1002/(SICI)1096-9896(199610)180:2<122::AID-PATH647>3.0.CO;2-C Erber, 1997, Aberrant p21WAF1/CIP1 protein accumulation in head-and-neck cancer, Int. J. Cancer, 74, 383, 10.1002/(SICI)1097-0215(19970822)74:4<383::AID-IJC4>3.0.CO;2-R Sakaguchi, 1998, Immunohistochemical analysis of p21 and p27 expression in gastric carcinoma, J. Jpn. Soc. Gastroenterol. Carcinogenesis, 10, 365 Ikeguchi, 1997, Relationship between the long-term effects of intraperitoneal chemotherapy and the expression of p53 and p21 in patients with gastric carcinoma at stage IIIa and stage IIIb, Int. Surg., 82, 170 Ogawa, 1997, Immunohistochemical study of p21 expression in gastric carcinoma, Jpn. J. Cancer Chemother., 24, 292 Aoyagi, 1997, The significance of p21 expression in gastric cancer, Jpn. J. Cancer Chemother., 24, 285 Ikeguchi, 1998, Expression of p53 and p21 are independent prognostic factors in patients with serosal invasion by gastric carcinoma, Dig. Dis. Sci., 43, 964, 10.1023/A:1018862214081 Gomyo, 1997, Expression of p21(waf1/cip1/sdi1), but not p53 protein, is a factor in the survival of patients with advanced gastric carcinoma, Cancer, 79, 2067, 10.1002/(SICI)1097-0142(19970601)79:11<2067::AID-CNCR3>3.0.CO;2-M 1998, Japanese classification of gastric carcinoma. 2nd English Edition, Gastric Cancer, 1, 1 Datto, 1995, Transforming growth factor β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism, Proc. Natl. Acad. Sci. USA, 92, 5545, 10.1073/pnas.92.12.5545 Rey, 1998, p21 WAF1/Cip1 is associated with cyclin D1CCND1 expression and tubular differentiation but is independent of p53 overexpression in human breast carcinoma, J. Pathol., 184, 265, 10.1002/(SICI)1096-9896(199803)184:3<265::AID-PATH8>3.0.CO;2-8 Bukholm, 1997, Interaction between bcl-2 and p21(WAF1/CIP1) in breast carcinoma with wild-type p53, Int. J. Cancer, 73, 38, 10.1002/(SICI)1097-0215(19970926)73:1<38::AID-IJC7>3.0.CO;2-2